Alaska Permanent Fund’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Alaska Permanent Fund’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-980,194	Closed	-$767K	–	421
2022 Q3	$767K	Buy	+980,194	New	+$2.06M	0.01%	298
2022 Q2	–	Sell	-980,194	Closed	-$6.15M	–	449
2022 Q1	$6.15M	Hold	980,194	–	–	0.1%	31
2021 Q4	$6.49M	Hold	980,194	–	–	0.12%	28
2021 Q3	$16M	Hold	980,194	–	–	0.32%	25
2021 Q2	$18.2M	Buy	980,194 +646,861	+194%	+$12.4M	0.33%	23
2021 Q1	$5.03M	Hold	333,333	–	–	0.09%	42
2020 Q4	$10.8M	Buy	+333,333	New	+$4.41M	0.19%	25

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Alaska Permanent Fund's CDAK Position: Q4 2022 in Review

Alaska Permanent Fund sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q4 2022, closing a stake of 980,194 shares — an estimated $767K sold.

Alaska Permanent Fund first reported a position in CDAK in Q4 2020 and held it in 7 quarters. The position peaked at $18.2M in Q2 2021. 40 funds tracked by Wall St. Rank hold CDAK as of Q4 2022.

Alaska Permanent Fund reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Alaska Permanent Fund sold 980,194 Codiak BioSciences, Inc. Common Stock shares in Q4 2022, an estimated $767K.
Alaska Permanent Fund first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Alaska Permanent Fund's Codiak BioSciences, Inc. Common Stock position peaked at $18.2M in Q2 2021.
40 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q4 2022.

Based on Alaska Permanent Fund's 13F filing for Q4 2022, filed 8 Feb 2023.